Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Short-term Investments (2016 - 2025)

Medifast's Short-term Investments history spans 16 years, with the latest figure at $78.0 million for Q4 2025.

  • For Q4 2025, Short-term Investments rose 9.18% year-over-year to $78.0 million; the TTM value through Dec 2025 reached $78.0 million, up 9.18%, while the annual FY2025 figure was $78.0 million, 9.18% up from the prior year.
  • Short-term Investments reached $78.0 million in Q4 2025 per MED's latest filing, up from $74.0 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $78.0 million in Q4 2025 to a low of $4.1 million in Q1 2022.
  • Average Short-term Investments over 5 years is $43.6 million, with a median of $55.5 million recorded in 2024.
  • Peak YoY movement for Short-term Investments: crashed 62.65% in 2021, then surged 35.39% in 2025.
  • A 5-year view of Short-term Investments shows it stood at $5.4 million in 2021, then dropped by 24.32% to $4.1 million in 2022, then skyrocketed by 1270.5% to $55.6 million in 2023, then rose by 28.44% to $71.4 million in 2024, then grew by 9.18% to $78.0 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Short-term Investments are $78.0 million (Q4 2025), $74.0 million (Q3 2025), and $61.0 million (Q2 2025).